Insights into Chronic Myeloid Leukemia (CML) Northwest

Perspectives of community physicians from the northwest of the US on the management of newly diagnosed and TKI-resistant/progressive CML

Northwest December 11, 2020

Faculty Chair

Javier Pinilla, MD, PhD

Moffitt Cancer Center, Tampa, FL, US

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A moderated virtual roundtable discussion focusing on treatment of CML was held on Friday, December 11, 2020
  • Disease state and data presentations were developed in conjunction with a medical expert from Moffitt Cancer Center
  • Insights on the following CML therapies were obtained: bosutinib, dasatinib, imatinib, nilotinib, omacetaxine, and ponatinib

GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT

  • Data collected via audience response system questioning and in-depth moderated discussion
  • The group of advisors comprised 12 community oncologists from California, Oregon, Wyoming, and Washington

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.